Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veltassa in heart failure patients (PEARL-HF)
NCT00868439Phase 2Completed
- Sponsor
- Relypsa, Inc.
- Start
- Apr 2009
- Primary completion
- Nov 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started Apr 2009; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT00868439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868439.